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Reply to the Editor:
We appreciate the response by Stöllberger,
Schneider, and Finsterer to our work1 and
thank them for their valuable comments.
As they mentioned, this series in dogs
was too small to confirm the long-term
safety and tissue response to the atrial ex-
clusion device (AED). However, the main
purpose of this series was to assess the
feasibility of the device implant during a
beating heart procedure, and thus we did
not include a control group or an atrial
fibrillation (AF) animal model, which
would have been helpful to evaluate the
safety and efficacy of this device.
Because of the main goal of this study
series, we also did not analyze biochemis-
try levels such as serum natriuretic peptide,
troponin, and creatine kinase, nor did we
obtain hemodynamic data derived from car-
diac catheterization with the exception of
left atrial (LA) pressure, heart rate, and sys-
temic arterial pressure. However, we per-
formed echocardiographic evaluations at
baseline, after AED implant, and at follow-
up. The pulmonary venous flow, transmi-
tral flow, and tissue Doppler imaging of the
mitral annular motion, which provide addi-
tional information regarding atrial and ven-
tricular filling and function,2,3 were evalu-
ated to assess the influence of left atrial
appendage (LAA) exclusion on LA func-
tion. The Doppler pulmonary venous flow
data suggested that LAA exclusion may af-
fect LA reservoir function without affect-
ing left ventricular diastolic function. After
we obtain echocardiographic data from our
next series of animals, we intend to report
more detailed echocardiographic evalua-
tion results in the near future.
With respect to the effect of device im-
plant on flow through the left circumflex ar-
tery, although specific evaluations including
coronary angiography and left circumflex
flow measurement with a flow probe were
not performed in this series, no macroscopic
findings of myocardial infarction at explant
surgery or gross examination were found.
As also mentioned, LAA exclusion may
cause adverse effects due to lack of serum
natriuretic peptide. In this series, there
were no clinical signs of heart failure, in-
cluding general fatigue or significant
changes in the weights and heart rates of
any dog, throughout the study.
To date, there have been no reports show-
ing clear evidence of a role of LAA exclusion
on stroke prevention for patients with non-
valvular AF. However, considering that LA
thrombi in more than 90% of cases of non-
valvular AF are located in the LAA4 and
surgical LAA ligation or excision does not
appear to have clinically important deleteri-
ous effects according to extensive study on
the Maze procedure by Cox and associates,5
LAA exclusion should be considered one of
the most important therapeutic options, espe-
cially for patients with AF who are not eligi-
ble for any anticoagulation therapy.
We agree with the potential concerns
related to hemodynamic and neurohumoral
consequences after LAA exclusion. In prep-
aration for a clinical AED application, fur-
ther evaluations using both a control and
AF animal model will definitely be required
to address the following points: (1) compe-
tency of LAA exclusion with various LAA
sizes, (2) long-term stability of the AED,
(3) potential LA thrombus formation due
to the device implant in an AF model,
and (4) neurohumoral effects of LAA ex-
clusion. We hope these further evaluations
will provide us with clearer information
that elucidates the exact role of LAA ex-
clusion.
We continue to work on this subject and
look forward to publishing more informa-
tion on the AED, the implantation proce-
dure for LAA exclusion, and its effects on
physiologic function.
Keiji Kamohara, MDa
Kiyotaka Fukamachi, MD, PhDa
A. Marc Gillinov, MDb
Department of Biomedical Engineeringa
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Is it really the number of clamps that
is responsible for worse postbypass
neurological outcomes?
To the Editor:
I read with interest the article by Dr Hammon
and colleagues1 comparing varying levels of
aortic manipulation in bypass surgery with
regard to postoperative neurobehavioral out-
comes. Even as the results are in some con-
currence with certain previous trials in this
direction, I do believe that this report re-
quires careful review before its recommen-
dations can be accepted.
First, the multiple aortic clamping group
had greater age, incidence of hyperlipid-
emia, and aortic fibrillation than the single
aortic clamping group, 3 independent pre-
dictors of postoperative stroke.2 Second,
the authors were unable to demonstrate any
significantly worse result in the 2 groups,
apart from the neuropsychologic deficit at
6-month follow-up. Recent prospective
neuropsychologic testing indicates that
these late neurocognitive deficits are likely
to be caused by established risk factors for
cerebral vasculopathy not having anything
to do with the bypass procedure itself.3
It is therefore arguable that the mere
reduction in the number of clamps would
have a significant effect on patient neuro-
logical profile after bypass surgery, consid-
ering that there exists already conflicting
evidence, with no additional benefit of re-
duction in clamp number being recorded
previously.4 Consensus in the literature has
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generally been that off-pump surgery re-
sults in better neurocognitive outcomes
than on-pump procedures. Apart from the
well-documented role of cardiopulmonary
bypass in emboli generation, this finding
might be explained by the interesting fact
that it is actually the act of aortic cannula-
tion rather than the application of the clamp
itself that is likely to generate the greatest
number of emboli.5 This might explain the
better results in the off-pump group and the
comparable results in the 2 on-pump
groups with different degree of clamp use
in this trial, obviating the little additional
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Reply to the Editor:
The authors of our article thank Omer
Ashraf for his comments relating to our
published article. We thank him for his
careful reading and analysis.
Ashraf makes the comment that it was
invalid to compare the multiple clamping
group with the single clamping group and
the off-pump coronary artery bypass group
because the group is significantly older. As
we stated in the “Discussion” section, we
have performed additional analyses on pa-
tients in all 3 groups who were older than
the age of 65 years and found that the
multiple clamping group still had a statis-
tically greater number of neurocognitive
deficits at 3 and 6 months, thus invalidating
this criticism. There was no significant dif-
ference between the incidence of hyperlip-
idemia or atrial fibrillation in all 3 groups.
Relating to late neuropsychologic test-
ing, as mentioned by Ashraf, in our expe-
rience deficits that occur after 6 months
often appear in a new domain and thus
might represent a new brain lesion, usually
related to spontaneous atherosclerotic em-
boli.
Our analysis of the literature would sug-
gest that the question of better neurological
or neurpsychologic outcomes with OPCAB
surgery has evidenced no clear difference,
as did this study. Evidence from our insti-
tution would also suggest that the more
applications of aortic clamps, cannulas, or
proximal anastomoses, the greater number
of emboli. The temperature at which those
emboli reach the brain is also important in
determining outcome.
We thank Ashraf for his comments and
appreciate the time spent on the article.
John W. Hammon, MD
Department of Cardiothoracic Surgery





Redo coronary bypass grafting: Role
of arterial grafts and time interval
To the Editor:
I read with interest the article by Sabik and
colleagues wherein they present their experi-
ence with reoperations in bypass surgery.1
Although the authors have conducted an
extensive temporal analysis, some impor-
tant concerns remain in reference to the
implications drawn from this report.
An important factor left unaddressed in
this study was the mean time for reopera-
tion. The time between primary and sec-
ondary bypass grafting is a determinant not
just of reoperation outcome but also of the
risk factors and patient characteristics
deeming reoperative therapy.2 Therefore it
is important to keep in consideration that
the risk factors for reoperation shown in
this report may not have uniform applica-
bility and may differ for patients undergo-
ing their second bypass at varying times
from their first surgery. The patency of
arterial and venous bypass conduits simi-
larly is likely to have individual alterations
at different points in time from the first
operation, illustrating the efficacy of arte-
rial grafts in reducing reoperation rate only
beyond a certain time interval from the
primary procedure.
The authors in this report, in cognizance
with certain trials in the past, advocate ex-
tensive use of arterial revascularization to
decrease reoperation rate on basis of their
findings. However, some amount of con-
flict prevails on this issue, with a number of
studies advocating no additional benefit of
using more than a single arterial graft.3,4 In
fact the reason that authors were unable to
document high reoperation rates among pa-
tients with multiple arterial grafts may be
owing to the notion that such patients are
more likely to undergo percutaneous angio-
plastic intervention rather than a second
bypass procedure. It is arguable, thus, that
broad use of arterial grafting would prevent
future myocardial ischemia in these pa-
tients. Even if a small extra degree of re-
operative risk was conferred by avoiding
use of more than 1 arterial graft, there
remains little overall clinical justification
for overuse of multiple arterial grafts,
bringing into view one of Dr Sabik’s own
recent reports that reoperation procedures
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